carbamazepine epoxide has been researched along with Drug Hypersensitivity in 2 studies
carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.
Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simper, GS | 1 |
| Hò, GT | 1 |
| Celik, AA | 1 |
| Huyton, T | 1 |
| Kuhn, J | 1 |
| Kunze-Schumacher, H | 1 |
| Blasczyk, R | 1 |
| Bade-Döding, C | 1 |
| Zakrzewska, JM | 1 |
| Ivanyi, L | 1 |
2 other studies available for carbamazepine epoxide and Drug Hypersensitivity
| Article | Year |
|---|---|
Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.
Topics: Allergens; Anticonvulsants; Antigen Presentation; B-Lymphocytes; Binding Sites; Carbamazepine; Cell | 2018 |
In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity.
Topics: Administration, Oral; Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Humans; Lymphocyte Acti | 1988 |